Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancer

ConclusionNevertheless, Hypo-RT has gained ground for patients with localized PCa and further improvements may be achieved by inclusion of genetically assessed radiation sensitivity. Several RCTs in Hypo-RT have shown non-inferior outcome and well-tolerated treatment toxicity by physician-rated scores. In the future, we suggest that toxicity should be measured by patient-reported outcome (PRO) using comparable questionnaires.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research